Form 4 for BCDA BioCardia, Inc.
Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-16 · accession 0001437749-22-029314 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-19 | 2022-12-16 | BCDA | McClung David | CFO | A - Grant | $1.68 | +8,928 | 87.4K | +11% | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-16 | A | A | 8,928 | $1.68 | 87,446 | D | — | — | (F1) These shares were purchased from the Issuer in a private placement that closed on December 16, 2022. |